{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18356", "batch_size": 260, "batch_pos": 211, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment uses 'climbed' to describe a stock market trend (background condition), not the threat's impact.", "method": "llm_batch", "batch_id": "batch_2_17752", "batch_size": 260, "batch_pos": 190, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The verb 'climbed' relates to a financial metric ('shares'), which is excluded from Q3 by the rules.", "method": "llm_batch", "batch_id": "batch_3_15208", "batch_size": 260, "batch_pos": 176, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question is present.", "method": "llm_batch", "batch_id": "batch_4_14732", "batch_size": 260, "batch_pos": 174, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment does not contain explicit calming language or keywords.", "method": "llm_batch", "batch_id": "batch_5_13684", "batch_size": 260, "batch_pos": 172, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_2152", "batch_size": 260, "batch_pos": 152, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_17876", "batch_size": 260, "batch_pos": 147, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 8, "answer": "no", "rationale": "The segment reports stock price reaction to a report, not capability or preparedness itself.", "method": "llm_batch", "batch_id": "batch_8_8824", "batch_size": 260, "batch_pos": 85, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 9, "answer": "yes", "rationale": "The segment reports a numerical metric ('climbed 2.4%') using a standard verb ('climbed').", "method": "llm_batch", "batch_id": "batch_9_688", "batch_size": 260, "batch_pos": 246, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
